Related references
Note: Only part of the references are listed.Pharmacokinetic/pharmacodynamic modeling of roxadustat's effect on LDL cholesterol in patients in Japan with dialysis-dependent chronic kidney disease and anemia
Akitsugu Takada et al.
DRUG METABOLISM AND PHARMACOKINETICS (2022)
Phase 3 Study of Roxadustat to Treat Anemia in Non-Dialysis-Dependant CKD
Tadao Akizawa et al.
KIDNEY INTERNATIONAL REPORTS (2021)
Roxadustat for the treatment of anaemia in chronic kidney disease patients not on dialysis: a Phase 3, randomized, open-label, active-controlled study (DOLOMITES)
Jonathan Barratt et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2021)
Effects of Roxadustat on the Anemia and Iron Metabolism of Patients Undergoing Peritoneal Dialysis
Keiji Hirai et al.
FRONTIERS IN MEDICINE (2021)
Roxadustat Treatment of Chronic Kidney Disease-Associated Anemia in Japanese Patients Not on Dialysis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial
Tadao Akizawa et al.
ADVANCES IN THERAPY (2019)
Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis
N. Chen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis
N. Chen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Hypoxia-inducible factor 1α activates insulin-induced gene 2 (Insig-2) transcription for degradation of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase in the liver
Seonghwan Hwang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors: A Potential New Treatment for Anemia in Patients With CKD
Nupur Gupta et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2017)
Erythropoiesis-Stimulating Agents: Dose and Mortality Risk
Guido Bellinghieri et al.
JOURNAL OF RENAL NUTRITION (2015)
Hypoxia Induces Dysregulation of Lipid Metabolism in HepG2 Cells via Activation of HIF-2α
Risheng Cao et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2014)
Hypoxia causes triglyceride accumulation by HIF-1-mediated stimulation of lipin 1 expression
Ilias Mylonis et al.
JOURNAL OF CELL SCIENCE (2012)
Prognostic significance of erythropoietin and erythropoietin receptor in gastric adenocarcinoma
Lin Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Interpretation and review of health-related quality of life data in CKD patients receiving treatment for anemia
David E. Leaf et al.
KIDNEY INTERNATIONAL (2009)
Factors that condition the response to erythropoietin in patients on hemodialysis and their relation to mortality
Juan M. Lopez-Gomez et al.
KIDNEY INTERNATIONAL (2008)
Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure - The anemia in chronic heart failure: Outcomes and Resource Utilization (ANCHOR) Study
Alan S. Go et al.
CIRCULATION (2006)
Anemia and end-stage renal disease in patients with type 2 diabetes and nephropathy
A Mohanram et al.
KIDNEY INTERNATIONAL (2004)
Share Paper
